Professor Megan Coffee, of the Grossman School of Medicine at New York University, in the Journal Computers, Materials and Continua, that a tool developed yesterday Monday by American and Chinese researchers that uses artificial intelligence, predicts which patients Coronavirus will develop severe pulmonary complications
Once deployed, this tool could allow doctors to treat certain patients as a priority as health systems in many countries around the world reach saturation
The tool has discovered several indicators that strongly assume a patient’s ability to develop Acute Respiratory Distress Syndrome (EDS), a complication of Covid-19 that fills the lungs with fluid and kills about 50% of people developing it. .
Intelligent analysis of data from 53 coronavirus patients at two hospitals in Wenzhou, en China, showed changes in the level of alanine aminotransfers, an enzyme present in the liver, the rate of hemoglobin and pain reports were the most accurate indications of a complication.
With other diagnostiquer factors, the tool was able to diagnose a risk of EDS with up to 80% accuracy.
Sex or age are not ans useful indicators, although other studies have indicated that patients aged 60 and over are a high-risk group. .
Artificial intelligence is already being used by dermatologists to predict which patients are likely to develop skin cancer. .
We are now trying to refine this tool with data from New York, epicenter of the pandemic in the United States, hoping that it can be ready to be deployed in April..